Therapeutic agent with quantitative consumption marker
First Claim
1. A method of determining patient compliance, comprising prescribing the ingestion by the patient of an active agent and a marker comprising a benzodiazepine or benzodiazepine metabolite, and subsequently analyzing the patient'"'"'s urine to confirm the presence of said marker and thus the ingestion of said prescribed active agent.
10 Assignments
0 Petitions
Accused Products
Abstract
Quantitative compliance markers and associated methods for monitoring patient compliance with medication prescriptions associated with compliance markers have been found to eliminate the need for specific quantitative relationships for each new drug tested. Such compliance markers and methods for monitoring patient compliance utilize pharmacologically inert substances, namely the weak acids benzodiazepines, or non-metabolizable substances in association with an underlying drug at a measurable dosage, so as to correlate compliance marker concentration with underlying medication concentration to determine amount of actual medication ingested.
34 Citations
4 Claims
- 1. A method of determining patient compliance, comprising prescribing the ingestion by the patient of an active agent and a marker comprising a benzodiazepine or benzodiazepine metabolite, and subsequently analyzing the patient'"'"'s urine to confirm the presence of said marker and thus the ingestion of said prescribed active agent.
Specification
-
- Resources
-
Current AssigneeUD Testing Incorporated (U.D. Testing)
-
Original AssigneeUD Testing Incorporated (U.D. Testing)
-
InventorsKell, Michael
-
Primary Examiner(s)KRASS, FREDERICK F
-
Application NumberUS09/220,533Time in Patent Office670 DaysField of Search514/220, 436/111, 436/112, 436/808, 436/901, 436/163US Class Current514/220CPC Class CodesG01N 33/948 Sedatives, e.g. cannabinoid...Y10S 436/808 Automated or kitY10S 436/901 Drugs of abuse, e.g. narcot...Y10T 436/173845 Amine and quaternary ammoniumY10T 436/174614 Tertiary amine
